Administration of biological therapy (BT) in rheumatoid arthritis (RA) patients is often associated with hematological complications, which result in switching among therapies. Thus, there is an instant need for suitable screening parameters that will help to individualize the therapy and minimize the onset of adverse effects. We analyzed the hematological profile of 99 RA patients receiving TNFα (Adalimumab - ADA, Golimumab - GOL, Etanercept - ETA) or IL-6 receptor (Tocilizumab - TCZ) inhibitors in order to find possible indicators to improve personalization of RA therapy. BTs significantly affect the levels of observed hematological parameters. In contrast to TNF-α inhibitors, TCZ normalized almost all monitored hematological parameters to values of healthy donors. Only GOL from the TNF-α inhibitors studied, was able to normalize neutrophil counts, as well as platelet indicators. Importantly, effects on the blood parameters (e.g. lymphocytes or platelet count) differ even within the same therapeutic group (anti-TNFα). Variable effects of individual biological agents in RA treatment point to importance to evaluate the patient’s hematological profile to improve the selection of suitable BT. It will help to personalize the administration of BT and prevent unnecessary switching from an effective therapy just because of provocation of avoidable hematological complications.
23 February 2026 in European Journal of Translational Myology
Diurnal strength fluctuations and the effects of time-of-day-specific training are well-documented in young adults but unclear in elderly women. This study investigated the effects of time-of-day-specific concurrent resistance-aerobic training on muscle strength, bone mass, and functional performance in elderly women. Twenty-six women (65-85 years) were randomized into morning (MTG), afternoon (ATG) and control (CON) groups. Training groups completed 12 weeks of concurrent resistance-aerobic training (3 sessions/week, factor of time). Outcomes included maximal knee extension torque (measured AM/PM, factor of test time), bone mineral density (DXA), and functional tests (30-s chair stand, Five Times Sit-to-Stand and Maximal gait speed). Analysis of strength confirmed a preserved diurnal rhythm, with morning performance deficit present (test time: p=0.0129). The group and time factors interaction approached significance (p=0.0624), further test showed that only ATG differed significantly from the CON, with broader improvement than MTG. The functional performance significantly improved in all tests (p<0.0001, p=0.0002, p=0.0200, respectively) compared to baseline, with no difference between groups. The bone mass parameters remained unchanged. The time-of-day-specific concurrent training improved strength and functional performance in both training groups with afternoon training producing superior strength gains compared to morning training. Unchanged bone parameters suggest longer interventions might be needed for osteogenic effects.